15
Views
0
CrossRef citations to date
0
Altmetric
Article

Evaluating the Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Patients with Cancer

, , &
Received 26 Oct 2023, Accepted 23 Apr 2024, Published online: 09 May 2024

References

  • Centers for Disease Control and Prevention, National Center for Health Statistics. Drug overdose death rates. 2024. Available from: https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates.
  • Smith JC, Ellenberger HH, Ballanyi K, Richter DW, Feldman JL. Pre-botzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science. 1991;254(5032):726–9. doi:10.1126/science.1683005.
  • Miller JR, Zuperku EJ, Stuth EAE, Banerjee A, Hopp FA, Stucke AG. A subregion of the parabrachial nucleus partially mediates respiratory rate depression from intravenous remifentanil in young and adult rabbits. Anesthesiology. 2017;127(3):502–14. doi:10.1097/ALN.0000000000001719.
  • Navarrete-Opazo AA, Cook-Snyder DR, Miller JR, Callison JJ, McCarthy N, Palkovic B, Stuth EAE, Zuperku EJ, Stucke AG. Endogenous glutamatergic inputs to the Parabrachial Nucleus/Kolliker-Fuse Complex determine respiratory rate. Respir Physiol Neurobiol. 2020;277:103401. doi:10.1016/j.resp.2020.103401.
  • Zedler B, Xie L, Wang L, Joyce A, Vick C, Brigham J, Kariburyo F, Baser O, Murrelle L. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in veterans’ health administration patients. Pain Med. 2015;16(8):1566–79. doi:10.1111/pme.12777.
  • Metcalfe L, Murrelle EL, Vu L, Joyce AR, Averhart Preston V, Maryon T, McDanald C, Yoo P. Independent validation in a large privately insured population of the risk index for serious prescription opioid-induced ­respiratory depression or overdose. Pain Med. 2020;21(10):2219–28. doi:10.1093/pm/pnaa026.
  • Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a screening risk index for serious prescription opioid-induced respiratory depression or overdose in a US commercial health plan claims database. Pain Med. 2018;19(1):68–78. doi:10.1093/pm/pnx009.
  • Wu S, Frey T, Wenthur CJ. Naloxone acceptance by outpatient veterans: a risk-prioritized telephone outreach event. Res Social Adm Pharm. 2021;17(5):1017–20. doi:10.1016/j.sapharm.2020.08.010.
  • Yates D, Frey T, Montgomery JC. Utilizing risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) scores to prioritize offer of rescue naloxone in an outpatient veteran population: a telephone-based project. Subst Abus. 2018;39(2):182–4. doi:10.1080/08897077.2018.1449171.
  • Shah NK, Chandler MW, Cetto AV, Luciani LL, Painter J, Bailey D. Retrospective Cohort Study of Safety Outcomes Associated with Opioid Rotations to Buprenorphine. J Pain Palliat Care Pharmacother. 2023;37(3):234–45. doi:10.1080/15360288.2023.2200412.
  • Sheikh S, Booth-Norse A, Holden D, Henson M, Dodd C, Edgerton E, James D, Kalynych C, Smotherman C, Hendry P, et al. Opioid Overdose Risk in Patients Returning to the Emergency Department for Pain. Pain Med. 2021;22(9):2100–5. doi:10.1093/pm/pnab047.
  • Tseregounis IE, Henry SG. Assessing opioid overdose risk: a review of clinical prediction models utilizing patient-level data. Transl Res. 2021;234:74–87. doi:10.1016/j.trsl.2021.03.012.
  • Arnold R, Weissman DE. Calculating opioid dose conversions #36. J Palliat Med. 2003;6(4):619–20. doi:10.1089/109662103768253731.
  • Xtampza ER (oxycodone) extended-release capsules. Collegium Pharmaceutical. 2024. Available from: https://www.xtampzaer.com/assets/pdf/Transition-kit.pdf.
  • Walker PW, Palla S, Pei B-L, Kaur G, Zhang K, Hanohano J, Munsell M, Bruera E. Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med. 2008;11(8):1103–8. doi:10.1089/jpm.2007.0285.
  • Centers for Medicare & Medicaid Services (CMS), U.S. Department of Health & Human Services. Opioid oral morphine milligram equivalent (MME) conversion factors table for prescription drug coverage. 2024. Available from: https://www.hhs.gov/guidance/document/opioid-oral-morphine-milligram-equivalent-mme-conversion-factors-0.
  • McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019;57(3):635–45 e4. doi:10.1016/j.jpainsymman.2018.12.001.
  • Yi X-Y, Ni S-F, Ghadami MR, Meng H-Q, Chen M-Y, Kuang L, Zhang Y-Q, Zhang L, Zhou X-Y. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med. 2018;45:25–32. doi:10.1016/j.sleep.2018.01.010.
  • Kim CA, Lelond S, Daeninck PJ, Rabbani R, Lix L, McClement S, Chochinov HM, Goldenberg BA. The impact of early palliative care on the quality of life of patients with advanced pancreatic cancer: the IMPERATIVE case-crossover study. Support Care Cancer. 2023;31(4):250. doi:10.1007/s00520-023-07709-3.
  • Hirayama H, Satomi E, Kizawa Y, Miyazaki M, Tagami K, Sekine R, Suzuki K, Yotani N, Sugano K, Abo H, et al. The effect of palliative care team intervention and symptom improvement using patient-reported outcomes: a multicenter prospective observational study. Support Care Cancer. 2023;31(7):439. doi:10.1007/s00520-023-07912-2.
  • Rhondali W, Nguyen L, Palmer L, Kang DH, Hui D, Bruera E. Self-reported constipation in patients with advanced cancer: a preliminary report. J Pain Symptom Manage. 2013;45(1):23–32. doi:10.1016/j.jpainsymman.2012.01.009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.